Work

Author response for "Safety and tolerability of semaglutide across the SUSTAIN and PIONEER phase IIIa clinical trial programmes"

Year: 2023

Type: peer-review

Source: Publons reviews and discussion

DOI: 10.1111/dom.14990/v2/response1

Authors: Vanita R. Aroda, Umut Erhan, Peter Jelnes, Juris J. Meier, Morten Tind Abildlund, Richard Pratley, Tina Vilsbøll, Mansoor Husain

Language: English

Topic: Diabetes Treatment and Management

Subfield: Endocrinology, Diabetes and Metabolism

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4318481761

Cites:

Cited by:

Related to: 5